3,059
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence: comment

&
Page 446 | Received 12 Apr 2023, Accepted 12 Apr 2023, Published online: 27 Apr 2023

References

  • Bazin R, Rochette S, Perreault J, et al. Evaluation of anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence in a vaccinated population. Infect Dis. 2023;1–6.
  • Joob B, Wiwanitkit V. Letter to the Editor: coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health. 2020;53(2):70.
  • Čiučiulkaitė I, Möhlendick B, Thümmler L, et al. GNB3 c.825c > T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet. 2022;13:932043.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.